Coalition for Affordable Drugs V LLC v. Biogen Idec Ma Inc

Robert Hahl

Biogen's multiple sclerosis patent challenged: all 20 claims for a 480mg DMF dose argued as obvious over prior art showing efficacy at a higher dose.

Judge	Cases	Inst. Rate	FWD Inv. Rate
Deborah Katz	60+	80%	88%
Fred E McKelvey	40+	69%	68%
Richard E Schafer	3	100%	33%
Sally G Lane	20+	82%	89%

Name	Ratings
Coalition for Affordable Drugs V LLC	L2 D
J Kyle Bass	L2 B
Hayman Orange Fund SPC Portfolio A	L2 D
IP Navigation Group LLC	L2 D
Hayman Credes Master Fund LP	L2 D
NXN Partners LLC	L1 B
Erich Spangenberg	L1 B

Name	Ratings
Finnegan Henderson Farabow Garrett & Dunner LLP	L5 D
Michael J. Flibbert	L3 B
Erin Sommers	-- -- --
Maureen Queler	-- -- --